Dataset Information

Reproductive Health in Men and Women with Vasculitis

ABSTRACT:

The purpose of this study is to learn about reproductive health, including fertility and pregnancies, in people with vasculitis.

All patients enrolled in the Vasculitis Clinical Research Consortium's Contact Registry will be invited via email to participate in this study. The Contact Registry includes people who self-identify as having one of 11 vasculities: Behçet's disease, central nervous system vasculitis, drug-induced vasculitis, eosinophilic granulomatosis with polyangiitis (Churg-Strauss), giant cell arteritis, granulomatosis with polyangiitis (Wegener's), Henoch-Schoenlein purpura, Kawasaki disease, microscopic polyangiitis, polyarteritis nodosa, or Takayasu arteritis. People voluntarily enroll in this Registry with the understanding that they will receive information about clinical studies for which they might be eligible. The introductory email included basic information about the study and all of the required elements for informed consent in a brief format. Once participants agreed to participate in the study, they were directed to an online questionnaire.

PROVIDER: phs001382 | dbGaP |

SECONDARY ACCESSION(S): PRJNA390827PRJNA390826

REPOSITORIES: dbGaP

ACCESS DATA

Dataset's files

Source:

			Action	DRS
	GapExchange_phs001382.v1.p1.xml	Xml
	dbGaPEx2.1.5.xsd	Other
	phs001382.v1-Documents.zip	Other
	Study_Report.phs001382.VCRC_5531.v1.p1.MULTI.pdf	Pdf
	manifest_phs001382.VCRC_5531.v1.p1.c1.GRU-IRB-PUB.pdf	Pdf

Items per page:

1 - 5 of 14

Similar Datasets

Project description:In Charcot-Marie-Tooth Disease (CMT) or inherited neuropathy research studies, it is the researcher who has selected what they believe to be important markers of impairment in function in patients. For example, it has been inferred that the wearing of ankle-foot-orthosis (AFOs), the use of walking aids such as canes, or the use of wheelchairs, are appropriate markers for “mild”, “moderate” or “severe” disability, respectively. Whether patients agree with this classification is unknown. By understanding what patients classify as mild, moderate and severe disability in CMT, we will know what our treatments need to target, to have a meaningful impact on the patients' functional status. Primary objective: The purpose of this study is to compare patient and healthcare provider impressions of what constitutes mild, moderate and severe disability in CMT. Target population: 200 patients who have self-registered at the Inherited Neuropathy Consortium Contact Registry, a web-based contact registry developed and supported by the Data Management and Coordinating Center (DMCC) for the Rare Diseases Clinical Research Consortium (RDCRN), located at the University of South Florida, and 200 health care professionals attending conferences about CMT, such as the 4th International CMT Consortium to be held in Potomac, Maryland, June 29-July 1, 2011 and the MDA Clinic Directors meeting in Las Vegas, NV March 4-7, 2012. Methods: A brief, anonymous, 20-item survey, in which we measure what the physician and the patient think are important indicators of disability in CMT, will be distributed by paper to 200 health care professionals, and via an online link to 200 patients self-registered with the RDCRN contact registry. Out of the 200 patients, approximately 25 patients will be requested to take the survey twice in a 2 to 4 week period. Analysis: We will measure the agreement between items in the physician and patient groups, and use items with high agreement in a Disability Severity Index.

Project description:Background and study aims Colorectal cancer is one of the most commonly occurring types of cancer worldwide. It negatively impacts people’s quality of life and is costly for both health services and patients. If colorectal cancer is found early, it’s easier to treat and there’s a better chance of recovery. Screening is a very effective way of detecting the disease in its early stages. However, of those who are invited to take part in screening in Ireland, only 41.9% take part. Research from around the world has shown that there may be many reasons for people not taking up screening (e.g. fear or negative attitudes to screening, lack of time or ability to access screening, poor knowledge about the benefits of screening or healthcare professionals not advising patients to take part in screening). This study aims to improve colorectal cancer screening uptake and improve patient outcomes. This will be done by developing a new screening invitation letter and a new information leaflet to encourage people to participate in colorectal cancer screening. Who can participate? People aged 60 years old who are invited to participate in colorectal cancer screening for the first time and randomly allocated by the National Screening Service to be invited to participate in the study What does the study involve? Participants are invited to complete an online consent and a questionnaire accessible online. They can complete this questionnaire whenever suits them, within 3 months from the receipt of the letter. This takes about 15 minutes. The data collected in the questionnaire will be treated anonymously. At the end of the questionnaire, participants will be offered the possibility to provide their contact details on another form if they wish to participate in an interview (about 30-60 minutes depending on their availability) to give more feedback about the BowelScreen programme and the materials they received. Their contact details will not be related to their questionnaire responses. Completing the questionnaire does not require them to participate in an interview.

Dataset Information

Reproductive Health in Men and Women with Vasculitis

Dataset's files

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets